Mar 1, 2023 · by the United States (US) FDA, confirming that RSVpreF is intended to treat a serious ... https://www.cdc.gov/vaccines/acip/meetings/downloads/ ...

May 18, 2023 · GSK's RSV vaccine AREXVY was recently approved by FDA for prevention of LRTD caused by RSV in individuals 60 years of age and older. Page 4. 4.

Aug 24, 2018 · 3 24 This guidance focuses primarily on the development of drugs with antiviral mechanism for RSV-related illness in infants and young children ...

Mar 1, 2023 · Palivizumab (Synagis; MedImmune), is a monoclonal antibody approved by the FDA for prevention of severe RSV disease in high-risk infants.

May 18, 2023 · FDA is convening this meeting of the Vaccines and Related Biological Products Advisory. Committee (VRBPAC) to discuss and vote on whether ...

May 3, 2023 · The FDA has approved Arexvy, the first RSV vaccine approved for use in the U.S. Arexvy is approved for the prevention of lower respiratory ...

2 days ago · This report describes safety findings a year after the respiratory syncytial virus (RSV) vaccine was recommended for adults 60 and older.

Mar 1, 2023 · Despite the significant medical need, there is currently no specific treatment or FDA- approved vaccine for the prevention of RSV infection or ...